Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$864,380
+$31,200 QoQ
Shares Held
2,387
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,794
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. AMGN ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
|
2,265 | $569,964 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $864,380 | 2,387 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $833,180 | 2,368 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $775,397 | 2,369 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $676,715 | 2,398 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $669,266 | 2,397 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $748,654 | 2,403 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $631,530 | 2,423 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $791,669 | 2,457 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $766,439 | 2,453 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $711,937 | 2,504 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $711,409 | 2,470 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $664,643 | 2,473 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $548,167 | 2,469 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $615,979 | 2,548 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,048,721 | 3,993 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $563,500 | 2,500 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $615,792 | 2,531 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $613,497 | 2,537 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $568,949 | 2,529 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $529,073 | 2,488 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $600,843 | 2,465 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $609,335 | 2,449 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $533,874 | 2,322 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $590,159 | 2,322 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $548,138 | 2,324 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $451,479 | 2,227 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||